PPARGC1A and ovarian carcinoma: In summary, Nrf2 cooperates with PGC1α to mediate antioxidant function and mitochondrial function, thereby regulating the maintenance of proteasome activity and influencing differences in cisplatin sensitivity in ovarian cancer cells (Figure 7(e)).